HLB Co., Ltd.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 028300.KQ | 004800.KS | 009540.KS | 329180.KS | 013030.KQ | 042660.KS | |
|---|---|---|---|---|---|---|
| Market cap | 4.31T | 2.06T | 17.40T | 28.44T | 363.05B | 15.06T |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | — | — | — | — | — |
| Price/book | — | — | — | — | — | — |
| Dividend yield | — | 3.82% | 6.18% | 3.56% | 4.31% | — |
| 1-year change | −38.42% | −0.61% | −41.07% | −46.31% | −8.20% | −58.23% |
| Today | −3.28% | −5.65% | −2.57% | −4.41% | −1.59% | −6.72% |
The closest companies by business and industry (Building Products & Equipment). Prices may be delayed up to 20 min.
Latest news
All 028300.KQ news ›HLB Customers Can Now Scan & Pay in China with HLB QR Pay
HLB brings greater spending certainty for customers with the ability to lock-in favorable exchange rates and make direct QR payments across 120 million merchants in China KUALA LUMPUR, Malaysia, Oct. 22, 2026 /PRNewswire/ — Hong Leong Bank…
Study Explores Two-Pronged HLB Approach
Daniel Cooper October 21, 2026HLB Management, Research A new study suggests that tackling both the bacterium responsible for huanglongbing (HLB) and the tree’s own response to infection may offer a better path for managing the disease. The…
HLB expects 15-20% price premium for Lyrfigtu ahead of US launch: CEO
HLB said Thursday that it expects its cholangiocarcinoma (CCA) drug Lyrfigtu (lirafugratinib) to be priced 15 to 20 percent above other fibroblast growth factor receptor 2 (FGFR2) inhibitors in the U.S. The company said it plans to launch…
High School Researcher Launches HLB Product
Daniel Cooper October 16, 2026HLB Management Aglave, now a senior at Strawberry Crest High School’s International Baccalaureate program in Tampa, has since commercialized her product and created a business to market it. She recently…
HLB Innovation's Verismo to Unveil Preclinical Results for Solid Tumor CAR-T
Published 16 Oct.2026 10:10(KST) Verismo Therapeutics, a U.S. subsidiary of HLB Innovation, will present preclinical results for its solid tumor CAR-T therapy at the Society for Immunotherapy of Cancer (SITC 2026) on Novemb
HLB drug targets U.S. phase 3 rebound as Korea eyes neurotrophic keratitis market
U.S. data in November could redeem RGN-259 as Oxervate's lone rival in a tight neurotrophic keratitis market As an investigational therapy for neurotrophic keratitis in early clinical stages succeeded in a global technology out-licensing…
HLB Chairman Expects U.S. Liver Cancer Drug Decision by Year-End
Korea's first economic newspaper, established in 1960. Providing comprehensive coverage of Korean business, finance, technology, and economic news. HLB (028300) Group is seeking U.S approval this year for its liver cancer treatment, a…
HLB pursues fourth FDA bid for liver cancer drug, cites resolved CMC issues
Resubmitted combo therapy faces FDA class decision soon as manufacturing lapses get cleared and partnership talks remain open HLB(028300) has made a fourth bid in the United States for approval of a new liver cancer drug. This time,…
HLB's Fate Hinges on November Phase 3 Results for Ophthalmic Drug — Will It Follow in Lyrfigtu's Footsteps?
South Korea's HLB Group is approaching a critical milestone as its ophthalmic drug candidate prepares for U.S. Phase 3 results in November. Just about a month after securing FDA approval for Lyrfigtu (ingredient name: lirafugratinib), a…
HLB Quarantine Expansion in California
APHIS is adding 155 square miles to the quarantined Murrieta area of Riverside and San Diego counties. This expansion impacts 125.6 acres of commercial citrus. The agency expanded the quarantined area in cooperation with the California…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- biz.chosun.com5
- en.sedaily.com3
- finance.biggo.com3
- asiae.co.kr2
- klsescreener.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 23 articles, not a forecast.